Sharon E. Underberg - 14 Feb 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Feb 2024, 17:58:49 UTC
Prior SEC filing
08 May 2023
Next SEC filing
20 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg

Key filing fact

Sharon E. Underberg filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 16 Feb 2024.

Key facts

  • This page summarizes Sharon E. Underberg's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
  • 14 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 16 Feb 2024, 17:58.

Change

  • Previous filing in this sequence was filed on 08 May 2023.
  • Current net transaction value: -$199,559.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IDXX transaction

Common Stock

Award

Transaction value
$0
Shares
+483
Change %
+11%
Price
$0.000000
Shares after
4,765
Date
14 Feb 2024
Ownership
Direct
Footnotes
F1
IDXX transaction

Common Stock

Award

Transaction value
$0
Shares
+216
Change %
+4.5%
Price
$0.000000
Shares after
4,981
Date
14 Feb 2024
Ownership
Direct
IDXX transaction

Common Stock

Award

Transaction value
$0
Shares
+138
Change %
+2.8%
Price
$0.000000
Shares after
5,119
Date
14 Feb 2024
Ownership
Direct
IDXX transaction

Common Stock

Award

Transaction value
$0
Shares
+173
Change %
+3.4%
Price
$0.000000
Shares after
5,292
Date
14 Feb 2024
Ownership
Direct
IDXX transaction

Common Stock

Award

Transaction value
$0
Shares
+176
Change %
+3.3%
Price
$0.000000
Shares after
5,468
Date
14 Feb 2024
Ownership
Direct
IDXX transaction

Common Stock

Tax liability

Transaction value
$199,559
Shares
-356
Change %
-6.5%
Price
$560.56
Shares after
5,112
Date
14 Feb 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IDXX transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Award

Transaction value
$0
Shares
+3,856
Change %
Price
$0.000000
Shares after
3,856
Date
14 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,856
Exercise price
$560.56
Footnotes
F2
IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Award

Transaction value
$0
Shares
+178
Change %
Price
$0.000000
Shares after
178
Date
14 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
178
Exercise price
$560.56
Footnotes
F3
IDXX transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+870
Change %
Price
$0.000000
Shares after
870
Date
14 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
870
Exercise price
Footnotes
F4
IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-483
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
483
Exercise price
Footnotes
F5
IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-216
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
216
Exercise price
Footnotes
F6
IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-138
Change %
-50%
Price
$0.000000
Shares after
137
Date
14 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
138
Exercise price
Footnotes
F7
IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-173
Change %
-33%
Price
$0.000000
Shares after
346
Date
14 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
173
Exercise price
Footnotes
F8
IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-176
Change %
-25%
Price
$0.000000
Shares after
528
Date
14 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
176
Exercise price
Footnotes
F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Includes a total of 37.247 shares purchased under the Issuer Employee Stock Purchase Plan on June 30, 2023, September 29, 2023 and December 29, 2023.

Footnote F2

Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.

Footnote F3

Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.

Footnote F4

Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.

Footnote F5

Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020.

Footnote F6

Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021.

Footnote F7

Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

Footnote F8

Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

Footnote F9

Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .